Rule 3.19A.2
Appendix 3Y
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity | Rhinomed Limited |
ABN | 12 107 903 159 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of director | Ron Dewhurst |
Date of last notice | 4 March 2022 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest |
|
Nature of indirect interest (including registered holder) |
|
Date of change |
(4) 19 April 2022 |
No. of securities held prior to change | (1) 2,000,000 - UNLISTED OPTIONS EXP 29/11/2023 @ $0.2998
|
+ Seechapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1
Class | (1) UNLISTED OPTIONS EXP 29/11/2023 @ $0.2998
|
Number acquired |
(4) 766,496 - ORDINARY FULLY PAID SHARES |
Number disposed |
(4) NIL |
Value/Consideration |
(4) $145,634 - ORDINARY FULLY PAID SHARES |
No. of securities held after change | (1) 2,000,000 - UNLISTED OPTIONS EXP 29/11/2023 @ $0.2998
|
Nature of change |
(4) Institutional Entitlement Offer @ $0.19 |
Part 2 - Change of director's relevant interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
Detail of contract | N/A |
Nature of interest | N/A |
Name of registered holder (if issued securities) | N/A |
Date of change | N/A |
No. and class of securities to which interest related prior to change | N/A |
Interest acquired | N/A |
Interest disposed | N/A |
Value/Consideration | N/A |
Interest after change | N/A |
Part 3 - +Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A |
If prior written clearance was provided, on what date was this provided? | N/A |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Rhinomed Limited published this content on 28 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 April 2022 05:03:09 UTC.